American International Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,455
Closed -$37.6K 3222
2023
Q1
$37.6K Buy
32,455
+5,743
+21% +$10.5K ﹤0.01% 2784
2022
Q4
$71.6K Buy
26,712
+198
+0.7% +$522 ﹤0.01% 2646
2022
Q3
$76K Buy
26,514
+374
+1% +$1.59K ﹤0.01% 2683
2022
Q2
$130K Buy
26,140
+2,038
+8% +$10.7K ﹤0.01% 2439
2022
Q1
$171K Sell
24,102
-1,696
-7% -$14K ﹤0.01% 2338
2021
Q4
$469K Sell
25,798
-773
-3% -$16.7K ﹤0.01% 1862
2021
Q3
$520K Sell
26,571
-297
-1% -$11.3K ﹤0.01% 1829
2021
Q2
$1.2K Buy
26,868
+26,429
+6,020% +$1.23M ﹤0.01% 1416
2021
Q1
$22 Buy
439
+191
+77% +$13K ﹤0.01% 3116
2020
Q4
$22 Buy
248
+59
+31% +$4.96K ﹤0.01% 3084
2020
Q3
$14K Buy
+189
New +$12K ﹤0.01% 3084

Other funds holding CELL

American International Group's CELL Position: Q2 2023 in Review

American International Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 32,455 shares — an estimated $37.6K sold.

American International Group first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $520K in Q3 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • American International Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 32,455 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
  • American International Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • American International Group's PhenomeX Inc. Common Stock position peaked at $520K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.